Safety Data Sheets

Total Page:16

File Type:pdf, Size:1020Kb

Safety Data Sheets SAFETY DATA SHEETS According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition Version: 1.0 Creation Date: Feb. 6, 2018 Revision Date: Feb. 6, 2018 1. Identification 1.1 GHS Product identifier Product name Cyclohexanone oxime 1.2 Other means of identification Product number A606108 Other names N-cyclohexylidenehydroxylamine 1.3 Recommended use of the chemical and restrictions on use Identified uses Used for research and development only.Intermediates Uses advised against no data available 1.4 Supplier's details Company Sangon Biotech (Shanghai) Co., Ltd. Address 698 Xiangmin Road, Songjiang, Shanghai 201611, China Telephone +86-400-821-0268 / +86-800-820-1016 Fax +86-400-821-0268 to 9 1.5 Emergency phone number Emergency phone +86-21-57072055 number Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours). 2. Hazard identification 2.1 Classification of the substance or mixture Acute toxicity - Oral, Category 4 2.2 GHS label elements, including precautionary statements Pictogram(s) Signal word Warning Cyclohexanone oxime Page 1 of 8 Hazard statement(s) H302 Harmful if swallowed Precautionary statement(s) Prevention P264 Wash ... thoroughly after handling. P270 Do not eat, drink or smoke when using this product. Response P301+P312 IF SWALLOWED: Call a POISON CENTER/doctor/…if you feel unwell. P330 Rinse mouth. Storage none Disposal P501 Dispose of contents/container to ... 2.3 Other hazards which do not result in classification no data available 3. Composition/information on ingredients 3.1 Substances Common names and CAS EC Chemical name Concentration synonyms number number Cyclohexanone Cyclohexanone oxime 100-64-1 202-874-0 ≥98% oxime 4. First-aid measures 4.1 Description of necessary first-aid measures General advice Medical attention is required. Consult a doctor. Show this safety data sheet (SDS) to the doctor in attendance. If inhaled Move the victim into fresh air. If breathing is difficult, give oxygen. If not breathing, give artificial respiration and consult a doctor immediately. Do not use mouth to mouth resuscitation if the victim ingested or inhaled the chemical. Following skin contact Take off contaminated clothing immediately. Wash off with soap and plenty of water. Consult a doctor. Following eye contact Rinse with pure water for at least 15 minutes. Consult a doctor. Following ingestion Rinse mouth with water. Do not induce vomiting. Never give anything by mouth to an unconscious person. Call a doctor or Poison Control Center immediately. 4.2 Most important symptoms/effects, acute and delayed ACUTE/CHRONIC HAZARDS: When heated to decomposition this compound emits toxic fumes of nitrogen oxides. Cyclohexanone oxime Page 2 of 8 4.3 Indication of immediate medical attention and special treatment needed, if necessary no data available 5. Fire-fighting measures 5.1 Extinguishing media Suitable extinguishing media Fires involving this material can be controlled with a dry chemical, carbon dioxide or Halon extinguisher. 5.2 Specific hazards arising from the chemical Flash point data for this chemical are not available; however, it is probably combustible. 5.3 Special protective actions for fire-fighters Wear self-contained breathing apparatus for firefighting if necessary. 6. Accidental release measures 6.1 Personal precautions, protective equipment and emergency procedures Avoid dust formation. Avoid breathing mist, gas or vapours. Avoid contacting with skin and eye. Use personal protective equipment. Wear chemical impermeable gloves. Ensure adequate ventilation. Remove all sources of ignition. Evacuate personnel to safe areas. Keep people away from and upwind of spill/leak. 6.2 Environmental precautions Prevent further spillage or leakage if it is safe to do so. Do not let the chemical enter drains. Discharge into the environment must be avoided. 6.3 Methods and materials for containment and cleaning up Collect and arrange disposal. Keep the chemical in suitable and closed containers for disposal. Remove all sources of ignition. Use spark-proof tools and explosion-proof equipment. Adhered or collected material should be promptly disposed of, in accordance with appropriate laws and regulations. 7. Handling and storage 7.1 Precautions for safe handling Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam. 7.2 Conditions for safe storage, including any incompatibilities Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials. 8. Exposure controls/personal protection 8.1 Control parameters Occupational Exposure limit values Cyclohexanone oxime Page 3 of 8 Component Cyclohexanone oxime CAS No. 100-64-1 Limit value - Eight hours Limit value - Short term ppm mg/m³ ppm mg/m³ Latvia 10 Remarks 8.2 Appropriate engineering controls Ensure adequate ventilation. Handle in accordance with good industrial hygiene and safety practice. Set up emergency exits and the risk-elimination area. 8.3 Individual protection measures, such as personal protective equipment (PPE) Eye/face protection Wear tightly fitting safety goggles with side-shields conforming to EN 166(EU) or NIOSH (US). Skin protection Wear fire/flame resistant and impervious clothing. Handle with gloves. Gloves must be inspected prior to use. Wash and dry hands. The selected protective gloves have to satisfy the specifications of EU Directive 89/686/EEC and the standard EN 374 derived from it. Respiratory protection If the exposure limits are exceeded, irritation or other symptoms are experienced, use a full-face respirator. Thermal hazards no data available 9. Physical and chemical properties Physical state Solid. Colour - Odour no data available Melting point/ freezing 89.05 °C. Remarks:No more information available from this point data source. Boiling point or initial >= 206 - <= 210 °C. Remarks:No more information available boiling point and boiling from this data source. range Flammability no data available Lower and upper no data available explosion limit / flammability limit Flash point 79°C(lit.) Auto-ignition no data available temperature Decomposition no data available temperature pH no data available Kinematic viscosity no data available Cyclohexanone oxime Page 4 of 8 Solubility less than 1 mg/mL at 20°C Partition coefficient n- Pow = 18.4. Temperature:25 °C.;log Pow = 1.265. octanol/water Temperature:25 °C. Vapour pressure 1.78 Pa. Temperature:20 °C. Density and/or relative 1.087 g/cm³. density Relative vapour density 3.91 (Relative to Air) Particle characteristics no data available 10. Stability and reactivity 10.1 Reactivity no data available 10.2 Chemical stability no data available 10.3 Possibility of hazardous reactions CYCLOHEXANONE OXIME reacts violently with fuming sulfuric acid at temperatures > 150°C. Several explosions or violent decompositions have occurred during distillation of aldoximes, which may be attributable to the formation of peroxides of various types. This is especially the case in the presence of acid, Chem. Eng. News, 1974, 52(35), 3. A nickel catalyzed aldoxime rearrangement to an amide, went out of control after changing the solvent employed, J. Loss Prev., 1993, 6(2), 69. 10.4 Conditions to avoid no data available 10.5 Incompatible materials no data available 10.6 Hazardous decomposition products no data available 11. Toxicological information Acute toxicity Oral: LD50 - rat (male) - 1 765.01 mg/kg bw. Remarks:Acc. to study report: data obtained excluding the results of the 1000 mg/kg group; including this group the LD50 was 1758.94 (95% CI: 1374.74-2250.52) mg/kg. Inhalation: no data available Dermal: approximate LD50 - rabbit (male/female) - > 5 000 mg/kg bw. Skin corrosion/irritation no data available Serious eye damage/irritation no data available Respiratory or skin sensitization no data available Cyclohexanone oxime Page 5 of 8 Germ cell mutagenicity no data available Carcinogenicity no data available Reproductive toxicity no data available STOT-single exposure no data available STOT-repeated exposure no data available Aspiration hazard no data available 12. Ecological information 12.1 Toxicity Toxicity to fish: LC50 - Pimephales promelas - 208 mg/L - 96 h. Toxicity to daphnia and other aquatic invertebrates: EC50 - Daphnia magna - 22 mg/L - 48 h. Toxicity to algae: EC50 - Desmodesmus subspicatus (previous name: Scenedesmus subspicatus) - 18.24 mg/L - 72 h. Toxicity to microorganisms: EC50 - Desmodesmus subspicatus (previous name: Scenedesmus subspicatus) - 18.24 mg/L - 72 h. 12.2 Persistence and degradability no data available 12.3 Bioaccumulative potential no data available 12.4 Mobility in soil no data available 12.5 Other adverse effects no data available 13. Disposal considerations 13.1 Disposal methods Product The material can be disposed of by removal to a licensed chemical destruction plant or by controlled incineration with flue gas scrubbing. Do not contaminate water, foodstuffs, feed or seed by storage or disposal. Do not discharge to sewer systems. Contaminated packaging Cyclohexanone oxime Page 6 of 8 Containers can be triply rinsed (or equivalent) and offered for recycling or reconditioning. Alternatively, the packaging can be punctured to make it unusable for other purposes and then be disposed of in a sanitary landfill. Controlled incineration with flue gas scrubbing is possible
Recommended publications
  • New Synthesis Routes for Production of Ε-Caprolactam by Beckmann
    New synthesis routes for production of ε-caprolactam by Beckmann rearrangement of cyclohexanone oxime and ammoximation of cyclohexanone over different metal incorporated molecular sieves and oxide catalysts Von der Fakultät für Mathematik, Informatik und Naturwissenschaften der RWTH Aachen University zur Erlangung des akademischen Grades eines Doktors der Naturwissenschaften genehmigte Dissertation vorgelegt von Anilkumar Mettu aus Guntur/Indien Berichter: Universitätprofessor Dr. Wolfgang F. Hölderich Universitätprofessor Dr. Carsten Bolm Tag der mündlichen Prüfung: 29.01.2009 Diese Dissertation ist auf den Internetseiten der Hochschulbibliothek online verfügbar. Dedicated to my Parents This work reported here has been carried out at the Institute for Chemical Technolgy and Heterogeneous Catalysis der Fakultät für Mathematik, Informatik und Naturwissenschaften in the University of Technology, RWTH Aachen under supervision of Prof. Dr. Wolfgang F. Hölderich between June 2005 and August 2008. ACKNOWLEDGEMENTS I would like to express my deepest sence of gratitude to my supervisor Prof. Dr. rer. nat. W. F. Hölderich for giving me the opportunity to do my doctoral study in his group. His guidance and teaching classes have allowed me to grow and learn my subject during my Ph.d. He has provided many opportunities for me to increase my abilities as a researcher and responsibilities as a team member. I am grateful for the financial support of this work from Sumitomo Chemicals Co., Ltd, Niihama, Japan (Part One) and Uhde Inventa-Fischer GmBH, Berlin (Part Two). Our collaborators at Sumitomo Chemicals Co., Ltd (Dr. C. Stoecker) and Uhde Inventa- Fischer GmBH (Dr. R. Schaller and Dr. A. Pawelski) provided thoughtful guidance and suggestions for each project.
    [Show full text]
  • United States Patent O Patented Sept
    2,719,] 16 United States Patent O Patented Sept. 27, 1955 i 2 mation of a resinous coating to a substantial degree. The amount of inhibitor employed should give effective‘ 2,719,116 action and will in most instances be small compared with PHOTOCHEMICAL PREPARATION OF OXIIVIES the amount of cyclic, hydro-aromatic compound present in the reactor. In general, the minimum amount of in Bernard B. Brown, Grand Island, N. Y., assignor to 01in hibitor to be employed will be at least about 0.5% by. Mathieson Chemical Corporation, a corporation of Virginia weight based upon the hydro-aromatic compound pres ent in the reactor. The maximum amount of acid to No Drawing. Application March 19, 1954, utilize will also vary with the particular acid selected Serial No. 417,490 10 but ordinarily little advantage will be derived if the amount employed is more than that which is soluble in 9 Claims. (Cl. 204—-158) the reacting mixture. I have found through several reactions conducted in the presence of my inhibitors that it is preferable to This invention relates to improvements in a method employ a saturated solution of the inhibitor in the re for the manufacturing of oximes of cyclic ketones. These acting mixture. A saturated solution of formic acid in oximes are valuable intermediates for the manufacturing cyclohexane will contain from about 0.85 to 1.25% by of superpolyamides. weight depending upon the temperature of the reaction In the copending application of Christoph Grundmann, and the extent of mixing. In some instances when the Serial No.
    [Show full text]
  • Cyclohexanone Oxime 20X29.Indd
    Proprietary process technology CYCLOHEXANONE OXIME AMMOXINATION OF CYCLOHEXANONE WITH TITANIUM SILICATE (TS-1) PROPIETARY CATALYST Versalis proprietary process technologies available for licensing II 1 Our company Our commitment to excellence, in quality of our Versalis – the petrochemical subsidiary of Eni – is products and services, makes our company an active a dynamic player in its industry sector facing the partner for the growth of customers involved in multifold market needs through different skills. petrochemical business. With a history as European manufacturer with more Through engineering services, technical assistance, than 50 years of operating experience, Versalis stands marketing support and continuous innovation, our as a complete, reliable and now global supplier in the knowledge is the key strength to customize any new basic chemicals, intermediates, plastics and elastomers project throughout all phases. market with a widespread sales network. Customers can rely on this strong service-oriented Relying on continuous development in its production outlook and benefit from a product portfolio that plants as well as in its products, strengthening the strikes a perfect balance of processability and management of the knowledge gained through its long mechanical properties, performance and eco- industrial experience, Versalis has become a worldwide friendliness. licensor of its proprietary technologies and proprietary catalysts. The strong integration between R&D, Technology and Engineering departments, as well as a deep market
    [Show full text]
  • Caprolactam, Supplement A
    Report No. 7-A CAPROLACTAM SUPPLEMENT A by HAROLD C. RIES March 1868 A private report by the PROCESS ECONOMICS PROGRAM STANFORD RESEARCH INSTITUTE MENLO PARK, CALIFORNIA I CONTENTS 1 INTRODUCTION . 1 2 SUMMARY.......................... 3 3 INDUSTRY STATUS. 17 4 CAPROLACTAM BY THE PHOTONITROSATION OF CYCLOHEXANE .... 27 Chemistry ......................... 27 Review of Processes .................... 29 Photochemical Lamps ................... 30 PNC Reactors ...................... 33 PNC Processes ...................... 35 Nitrosyl Chloride Production .............. 37 Caprolactam Purification ................ 38 8 Process Description .................... 42 Nitrosyl Chloride Production .............. 44 Photonitrosation of Cyclohexane ............. 45 Rearrangement ...................... 47 Caprolactam Purification ................ 48 Ammonium Sulfate Recovery ................ 49 Process Discussion .................... 68 Costs ........................... 72 Capital Investment ................... 72 Production Costs .................... 81 5 CYCLOHEXANONE FROM CYCLOHEXANE .............. 87 Review of Processes .................... a7 Cyclohexane Oxidation .................. 87 Dehydrogenation of Cyclohexanol ............. 87 Stamicarbon Process ................... 90 Process Description .................... 92 Cyclohexane Oxidation (I.F.P. Process) ......... 92 Cyclohexanone from Mixed Oil .............. 96 costs ........................... 97 E Capital Investment ................... 97 100 8 Production Costs .................... 8 iii CONTENTS
    [Show full text]
  • Cyclohexanone Oxime
    National Toxicology Program Toxicity Report Series Number 50 NTP Technical Report on Toxicity Studies of Cyclohexanone Oxime (CAS No. 100-64-1) Administered by Drinking Water to B6C3F1 Mice Leo T. Burka, Ph.D., Study Scientist National Toxicology Program Post Office Box 12233 Research Triangle Park, NC 27709 United States Department of Health and Human Services Public Health Service National Institutes of Health Note to the Reader The National Toxicology Program (NTP) is made up of four charter agencies of the United States Department of Health and Human Services (DHHS): the National Cancer Institute (NCI) of the National Institutes of Health; the National Institute of Environmental Health Sciences (NIEHS) of the National Institutes of Health; the National Center for Toxicological Research (NCTR) of the Food and Drug Administration; and the National Institute for Occupational Safety and Health (NIOSH) of the Centers for Disease Control. In July 1981, the Carcinogenesis Bioassay Testing Program was transferred from NCI to NIEHS. NTP coordinates the relevant Public Health Service programs, staff, and resources that are concerned with basic and applied research and with biological assay development and validation. NTP develops, evaluates, and disseminates scientific information about potentially toxic and hazardous chemicals. This knowledge is used for protecting the health of the American people and for the primary prevention of disease. NTP designs and conducts studies to characterize and evaluate the toxicologic potential of selected chemicals in laboratory animals (usually two species, rats and mice). Chemicals selected for NTP toxicology studies are chosen primarily on the bases of human exposure, level of production, and chemical structure.
    [Show full text]
  • Environmentally Friendly Beckmann Rearrangement of Oximes Catalyzed by Metaboric Acid in Ionic Liquids
    Catalysis Communications 6 (2005) 225–228 www.elsevier.com/locate/catcom Environmentally friendly Beckmann rearrangement of oximes catalyzed by metaboric acid in ionic liquids Shu Guo, Youquan Deng * Center for Green Chemistry and Catalysis, Lanzhou Institute of Chemical Physics, Chinese Academy of Sciences, Lanzhou 730000, PR China Received 8 November 2004; accepted 10 January 2005 Available online 3 February 2005 Abstract Beckmann rearrangement of several oximes catalyzed by metaboric acid was studied in room temperature ionic liquids. Espe- cially for conversion of cyclohexanone oxime into e-caprolactam, excellent conversion and selectivity were obtained. Ó 2005 Elsevier B.V. All rights reserved. Keywords: Beckmann rearrangement; Oxime; Metaboric acid; Ionic liquid 1. Introduction as the requirement of high temperature above 250 °C and rapid deactivation of catalyst due to the coke for- Catalytic rearrangement of oximes into the corre- mation [4,5]. sponding lactams has long been an important subject Boric acid has low mammalian toxicity and is widely for catalyst researchers, particularly with respect to used as antiseptic in the hospital. When boric acid is the commercial production of e-caprolactam in which heated above 100 °C, it is dehydrated and converted into concentrated sulfuric acid is employed and a large metaboric acid (Scheme 1). Chandrasekhar and Gopal- amount of ammonium sulfate is produced as a by- aiah [6] investigated solid metaboric acid catalyzed product. Great efforts have been put into the develop- Beckmann rearrangement of ketoximes, but involved ment of the ammonium sulfate free processes. Re- reaction conditions were rigorous (for cyclohexanone cently, the Beckmann rearrangement in supercritical oxime instance, it requires high reaction temperatures water has been reported [1–3], in which, although there near 140 °C and more than 40 h reaction time.
    [Show full text]
  • Reduction of Ketoximes to Amines by Catalytic Transfer Hydrogenation Using Raney Nickel and 2-Propanol As Hydrogen Donor
    University of Tennessee at Chattanooga UTC Scholar Student Research, Creative Works, and Honors Theses Publications 5-2014 Reduction of ketoximes to amines by catalytic transfer hydrogenation using Raney Nickel and 2-propanol as hydrogen donor Katherynne E. Taylor University of Tennessee at Chattanooga Follow this and additional works at: https://scholar.utc.edu/honors-theses Part of the Catalysis and Reaction Engineering Commons, and the Chemistry Commons Recommended Citation Taylor, Katherynne E., "Reduction of ketoximes to amines by catalytic transfer hydrogenation using Raney Nickel and 2-propanol as hydrogen donor" (2014). Honors Theses. This Theses is brought to you for free and open access by the Student Research, Creative Works, and Publications at UTC Scholar. It has been accepted for inclusion in Honors Theses by an authorized administrator of UTC Scholar. For more information, please contact [email protected]. Reduction of Ketoximes to Amines by Catalytic Transfer Hydrogenation Using Raney Nickel® and 2-Propanol! as Hydrogen Donor ! ! By Katherynne E. Taylor ! Departmental Thesis The University of Tennessee at Chattanooga Department of! Chemistry Project Director: Dr. Robert Mebane Examination Date: March 20, 2014 Committee Members: Dr. Jisook Kim Dr. John Lee Dr. Robert Mebane Dr. Abdul! Ofoli ! _________________________________________________________ Project Director _________________________________________________________ Department Examiner _________________________________________________________ Department Examiner _________________________________________________________
    [Show full text]
  • United States Patent Office Patented Mar
    2,879,215 United States Patent Office Patented Mar. 24, 1959 1 temperatures it is necessary in general, by reason of the 2,879,215 position of the freezing point of the hydrocarbons, to add diluents which are inert to the reactants, as for exam PRODUCTION OF CYCLOALEPHATIC KETOXIMES ple carbon tetrachloride, chloroform or benzene. The AND THER HYDROCHLORDES addition of diluents may also be advantageous, however, Walter Reppe, Hans-Joachim Ried, and Otto von Schickh, at room temperature in order to facilitate the separation Ludwigshafen (Rhine), Germany, assignors to Badische and removal of the oxime hydrochlorides. - Anilin- & Soda-Fabrik Aktiengesellschaft, Ltdwigs The free oxime may be recovered in known manner hafen (Rhine), Germany from the separated oxime hydrochlorides. For this pur No Drawing. Application August 6, 1956 O pose the oxime hydrochloride is dissolved for example in a little water and neutralized with substances having Serial No. 602,445 an alkaline reaction, such as caustic soda or potash solu 8 Claims. (C. 204-158) tions, alkali carbonates or ammonia. The free oximes in general separate immediately in crystallized form when This invention relates to an improved process for the 5 working carefully. production of cycloaliphatic ketoximes and their hydro Suitable cycloaliphatic hydrocarbons for the process chlorides. are for example cyclopentane, cyclohexane, cycloheptane, It is known that from the reaction products of nitrosyl cyclooctane and their alkyl derivatives. chloride with cycloaliphatic hydrocarbons in light, the AS active light there may be used the emissions of corresponding ketoximes can be recovered. The yields, 20 mercury vapor or other metal vapor lamps, electric arcs, however, are very unsatisfactory; it is only by main fluorescent tubes, incandescent bulbs and also sunlight.
    [Show full text]
  • (CDR) by CASRN Or Accession Number
    List of Chemicals Reported for the 2012 Chemical Data Reporting (CDR) by CASRN or Accession Number For the 2012 CDR, 7,674 unique chemicals were reported by manufacturers (including importers). Chemicals are listed by CAS Registry Number (for non-confidential chemicals) or by TSCA Accession Number (for chemicals listed on the confidential portion of the TSCA Inventory). CASRN or CASRN or ACCESSION ACCESSION NUMBER CA INDEX NAME or GENERIC NAME NUMBER CA INDEX NAME or GENERIC NAME 100016 Benzenamine, 4-nitro- 10042769 Nitric acid, strontium salt (2:1) 10006287 Silicic acid (H2SiO3), potassium salt (1:2) 10043013 Sulfuric acid, aluminum salt (3:2) 1000824 Urea, N-(hydroxymethyl)- 10043115 Boron nitride (BN) 100107 Benzaldehyde, 4-(dimethylamino)- 10043353 Boric acid (H3BO3) 1001354728 4-Octanol, 3-amino- 10043524 Calcium chloride (CaCl2) 100174 Benzene, 1-methoxy-4-nitro- 100436 Pyridine, 4-ethenyl- 10017568 Ethanol, 2,2',2''-nitrilotris-, phosphate (1:?) 10043842 Phosphinic acid, manganese(2+) salt (2:1) 2,7-Anthracenedisulfonic acid, 9,10-dihydro- 100447 Benzene, (chloromethyl)- 10017591 9,10-dioxo-, sodium salt (1:?) 10045951 Nitric acid, neodymium(3+) salt (3:1) 100185 Benzene, 1,4-bis(1-methylethyl)- 100469 Benzenemethanamine 100209 1,4-Benzenedicarbonyl dichloride 100470 Benzonitrile 100210 1,4-Benzenedicarboxylic acid 100481 4-Pyridinecarbonitrile 10022318 Nitric acid, barium salt (2:1) 10048983 Phosphoric acid, barium salt (1:1) 9-Octadecenoic acid (9Z)-, 2-methylpropyl 10049044 Chlorine oxide (ClO2) 10024472 ester Phosphoric acid,
    [Show full text]
  • Direct Cyclohexanone Oxime Synthesis Via Oxidation-Oximization of Cyclohexane with Ammonium Acetate
    Electronic Supplementary Material (ESI) for ChemComm. This journal is © The Royal Society of Chemistry 2020 Supporting Information Direct cyclohexanone oxime synthesis via oxidation-oximization of cyclohexane with ammonium acetate Ling Peng, Chan Liu, Na Li, Wenzhou Zhong*, Liqiu Mao*, Steven Robert Kirk and Dulin Yin National & Local United Engineering Laboratory for New Petrochemical Materials & Fine Utilization of Resources, Key Laboratory of Chemical Biology Traditional Chinese Medicine Research Ministry of Education, College of Chemistry and Chemical Engineering, Hunan Normal University, Changsha 410081, PR China *Corresponding authors: Wenzhou Zhong and Liqiu Mao Fax: +86-731-88872531; Tel.: +86-731-88872576 E-mail: [email protected] (W. Zhou); [email protected] (L. Mao) 1. Experimental 1.1 Catalyst preparation The hollow-structured TS-1 was synthesized under hydrothermal condition by a dissolution- recrystallization process in tetrapropylammonium hydroxide (TPAOH) solution.1 First, tetraethyl orthosilicate (TEOS), titanium butoxide (TBOT), TPAOH solution and distilled deionized water were mixed in a 1:0.01:0.4:40 molar ratio forming a clear solution, which was hydrolyzed for 2 h at 60 oC. The obtained gel was transferred to a Teflon-lined stainless steel autoclave and crystallized at 170 oC for 3 days. The white solid was filtrated and washed with large amounts of deionized water and dried at 120 oC for 24 h, followed by calcination at 500 oC for 10 h to remove the residual structure directing reagent. Secondly, the obtained solid TS-1 was treated with H2SO4 solution (a weight ratio of the previous calcined TS-1:H2SO4:water=10:1.2:140), and the acid- treated solid TS-1 was dispersed in TPAOH solution (a weight ratio of molecular sieve: TPAOH: water=10:1.5:125).
    [Show full text]
  • US5312915.Pdf
    ||||||||||||||||| US005312915A United States Patent (19) 11 Patent Number: 5,312,915 Yashima et al. (45) Date of Patent: May 17, 1994 54 PROCESS FOR PRODUCING tion of Carbon Resources, 1992 with our English trans EPSILON-CAPROLACTAM lation, The Society of Polymer Science, Japan. (75) Inventors: Tatsuaki Yashima; Takayuki 64th Autumn Annual Meeting of the Chemical Society Komatsu, both of Tokyo, Japan of Japan, Preliminary Contributions for the Lectures I, Symposium, Chemical Society of Japan, Union Confer 73 Assignee: Sumitomo Chemical Company, ence of Chemistry-relating Societies and Associations. Limited, Osaka, Japan Manuscripts for slide viewers use by K. Miura et all at 21 Appl. No.: 118,721 “Lectures for publishing Research on the Chemical Utilization of Carbon Resources', with our English (22 Filed: Sep. 10, 1993 translation, 1992. 30 Foreign Application Priority Data Manuscripts for slide viewers use by Mr. K. Miura et al Mar. 4, 1993 JP Japan .................................. 5-04384.5 at 64th Autumn Annual Meeting of the Chemical Soci ety of Japan with our English translation. 51) Int. Cl. ............................................ E07D 201/04 52 U.S. Cl. .................................................... 540/536 Primary Examiner-Robert T. Bond 58) Field of Search ......................................... 540/536 Attorney, Agent, or Firm-Cushman, Darby & Cushman 56) References Cited (57) ABSTRACT U.S. PATENT DOCUMENTS e-Caprolactam is produced efficiently with high selec 3,503,958 3/1970 Landis ................................. 540/536 tivity by contacting cyclohexanone oxime in gas phase 4,359,421 l 1/1982 Bell et al. ............................ 540/536 with a solid catalyst which is a crystalline zeolite having 4,709,024 11/1987 Sato et al.
    [Show full text]
  • ANALYSIS of ALTERNATIVES Public Version
    ANALYSIS OF ALTERNATIVES Public version Legal name of applicant(s): Grupa Azoty S.A. Submitted by: Grupa Azoty S.A. Substance: Trichloroethylene Use title: Industrial use as a process chemical in caprolactam purification Use number: 1 Disclaimer This report has been prepared by Risk & Policy Analysts Ltd and Forschungs- und Beratungsinstitut Gefahrstoffe GmbH, with reasonable skill, care and diligence under a contract to the client and in accordance with the terms and provisions of the contract. Risk & Policy Analysis Ltd and Forschungs- und Beratungsinstitut Gefahrstoffe GmbH will accept no responsibility towards the client and third parties in respect of any matters outside the scope of the contract. This report has been prepared for the client and we accept no liability for any loss or damage arising out of the provision of the report to third parties. Any such party relies on the report at their own risk. Table of contents 1 Summary..............................................................................................................................1 1.1 Background to this analysis of alternatives ....................................................................................1 1.2 Overview of Grupa Azoty S.A. supply chain....................................................................................2 1.3 Potential alternatives for TCE .........................................................................................................3 1.4 Suitability of potential alternatives for TCE....................................................................................4
    [Show full text]